Granahan Investment Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.28M | Buy |
991,388
+441,446
| +80% | +$4.13M | 0.38% | 69 |
|
|
2025
Q1 | $6.76M | Sell |
549,942
-355,380
| -39% | -$4.37M | 0.34% | 78 |
|
|
2024
Q4 | $12M | Buy |
905,322
+240,557
| +36% | +$3.18M | 0.5% | 59 |
|
|
2024
Q3 | $12.8M | Buy |
664,765
+70,379
| +12% | +$1.35M | 0.5% | 60 |
|
|
2024
Q2 | $12.2M | Buy |
594,386
+197,508
| +50% | +$4.05M | 0.49% | 68 |
|
|
2024
Q1 | $9.45M | Buy |
396,878
+75,967
| +24% | +$1.81M | 0.33% | 89 |
|
|
2023
Q4 | $6.93M | Buy |
+320,911
| New | +$6.93M | 0.23% | 113 |
|